Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia
- 1 December 1984
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 58 (4) , 723-727
- https://doi.org/10.1111/j.1365-2141.1984.tb06119.x
Abstract
A patient from the Caribbean area with active T-cell lymphoma-leukemia was primarily treated with deoxycoformycin (DCF), 5 mg/m2 i.v. on 3 consecutive days, followed by 5 mg/m2 i.v. weekly. A complete remission was attained and maintained during several weeks with DCF. A single consolidation course with other cytostatics was then given. The patient continues in complete remission without further therapy, 24 mo. after diagnosis, 17 mo. after the last cytostatic drugs. T-cell lymphoma-leukemia has a bad prognosis with conventional anti-lymphoma therapy but was exquisitely sensitive to DCF in this patient.This publication has 7 references indexed in Scilit:
- Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the CaribbeanBlood, 1984
- Human T-cell leukemia-lymphoma virus and adult T-cell leukemiaPublished by American Medical Association (AMA) ,1983
- ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIESThe Lancet, 1982
- THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIAThe Lancet, 1981
- The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyBlood, 1981
- THE BIOCHEMICAL AND CLINICAL CONSEQUENCES OF 2'-DEOXYCOFORMYCIN IN REFRACTORY LYMPHOPROLIFERATIVE MALIGNANCY1981
- Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.Proceedings of the National Academy of Sciences, 1979